19 noviembre 2007

Pharma Mar consigue Patente US : Combined use of ecteinascidin-743 and platinum antineoplastic compounds .

Publication number: US2007128201
Publication date: 2007-06-07
Inventor: D INCALCI MAURIZIO (IT); GIANNI LUCA (IT); GIAVAZZI RAFFAELLA (IT); MARTIN MARGARITA G (ES); JUDSON IAN (GB); DONAQUE JOSE M J (ES); SESSA CRISTIANA (CH)
Applicant: PHARMA MAR S A U (ES)
Classification:
- international: A61K39/395; A61K31/282; A61K31/495; A61K31/555; A61K33/24; A61P35/00; A61K39/395; A61K31/28; A61K31/495; A61K31/555; A61K33/24; A61P35/00;
- European: A61K31/282; A61K31/495; A61K31/555; A61K33/24
Application number: US20040558133 20040601
Priority number(s): GB20030012407 20030529; WO2004GB02319 20040601


Abstract of US2007128201
ET-743 can be used to mitigate resistance to and potentiate the cytotoxic effects of a platinum coordination complex anti-neoplastic agent in a human cancer patient.

Eficacia de los ultrasonidos en la detección de tumores de ovario .

Genentech dice Avastin da esperanzas contra el cáncer cerebral .